Why the study?
Pulmonary embolism is a life-threatening disease where risk stratification can guide clinical decisions, patient disposition, and treatment.
Risk stratification in acute pulmonary embolism is crucial for optimizing patient disposition and tailoring treatment to reduce mortality and bleeding risks.
Answers are grounded in this paper and cite their sources.
Review synthesizes PE risk tools; reinforces guidelines while leaving optimal model selection open.
INTRODUCTION: Pulmonary embolism (PE) is a life-threatening disease. Risk stratification in patients with acute PE can guide clinical decisions. Clinical assessment, including hemodynamics, respiratory parameters, patient history, and right ventricle evaluation, has a pivotal role in this scope. AREAS COVERED: This review aims to describe: i) the role of individual tools for prognostic stratification, from simple clinical parameters to the models suggested by international guidelines; ii) the implications of risk stratification in terms of patient disposition and treatment. The bleeding risk assessment in acute PE was also reviewed. The literature search was performed in PubMed and Embase to address these issues. EXPERT OPINION: Prognostic assessment is essential to proceed with life-saving treatments in hemodynamically unstable patients and consider home treatment or short hospital stay in patients at low risk for death. In hemodynamically stable patients, risk stratification allows the implementation of personalized treatment pathways to reduce the risk of death, early PE recurrence, and bleeding. With the aim of optimizing healthcare resources, risk stratification may suggest appropriate patient disposition.
No takes yet. Share an insight, caveat, or question.
Maraziti et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: